Patents by Inventor Alfredo Rivera Hernández

Alfredo Rivera Hernández has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment
    Patent number: 7820200
    Abstract: The invention relates to a substained release form of hydralazine for use in cancer therapy. The substained release form of hydralazine can be used to obtain a constant concentration of the active principle in the blood, thereby enabling the demethylating effect of the hydralazine without producing the hypotensive action thereof, such that the inventive composition can be used in cancer therapy.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: October 26, 2010
    Inventors: Luis Estrada Flores, Alfonso Dueñas González, Arturo Borbolla García, Raul Serna Martinez, Alfredo Rivera Hernández, Alejandro Mohar Betancourt